Daily News Podcast

Daily News Special: SABCS

Publish date: January 12, 2019

 

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Most data reassure regarding TNF inhibitors and cancer
MDedge Dermatology
Canadian agency reports rare, severe skin reactions to cancer drug
MDedge Dermatology
Don’t bypass breasts and nipples in routine skin exams
MDedge Dermatology
Apple’s ResearchKit
MDedge Dermatology
Contamination prompts voluntary injectables recall
MDedge Dermatology
ASCO: Precision medicine initiatives take wing
MDedge Dermatology
Early infection-related hospitalization portends poor breast cancer prognosis
MDedge Dermatology
Unavoidable, random DNA replication errors are the most common cancer drivers
MDedge Dermatology
Breakthrough cancer gene assay approved, CMS proposes coverage
MDedge Dermatology
Poor-prognosis cancers linked to highest suicide risk in first year
MDedge Dermatology